Published in J Cell Biol on June 24, 2002
A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature (2009) 5.65
Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A (2006) 4.54
The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A (2005) 4.12
Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol (2007) 3.76
Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell (2010) 3.41
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci U S A (2006) 3.34
Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A (2008) 3.26
In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci U S A (2003) 3.19
Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell (2012) 2.84
Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A (2005) 2.77
Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci U S A (2010) 2.69
The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology (2008) 2.56
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res (2006) 2.02
Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc (2010) 1.96
p63 regulates commitment to the prostate cell lineage. Proc Natl Acad Sci U S A (2005) 1.80
Stem cells in prostate cancer initiation and progression. J Clin Invest (2007) 1.76
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res (2010) 1.64
Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol (2010) 1.63
p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc Natl Acad Sci U S A (2013) 1.57
Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors. Stem Cells Transl Med (2013) 1.50
Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the Prostate. PLoS One (2016) 1.41
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc Natl Acad Sci U S A (2008) 1.41
BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol (2005) 1.40
TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol (2005) 1.35
Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol (2011) 1.32
Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats. J Clin Invest (2012) 1.28
Prostate cancer stem cells. J Pathol (2009) 1.26
Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One (2009) 1.24
Concise review: Kidney stem/progenitor cells: differentiate, sort out, or reprogram? Stem Cells (2010) 1.23
Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia (2007) 1.22
Roles for Hedgehog signaling in adult organ homeostasis and repair. Development (2014) 1.17
Anchorage-independent culture maintains prostate stem cells. Dev Biol (2007) 1.15
GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology (Bethesda) (2009) 1.14
Of microenvironments and mammary stem cells. Stem Cell Rev (2007) 1.14
Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies. Mol Med (2011) 1.13
Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol Oncol (2010) 1.11
Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells (2010) 1.09
Lung alveolar septation defects in Ltbp-3-null mice. Am J Pathol (2005) 1.08
Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer. PLoS One (2009) 1.08
Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. PLoS One (2010) 1.07
Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Curr Protoc Pharmacol (2013) 1.06
Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS One (2012) 1.04
Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. BMB Rep (2011) 1.04
New insights into prostate cancer stem cells. Cell Cycle (2013) 1.02
Prostate cancer stem cells. Clin Genitourin Cancer (2012) 0.96
Axin2 expression identifies progenitor cells in the murine prostate. Prostate (2008) 0.95
miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Rep (2014) 0.94
Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells. Nat Commun (2014) 0.94
Sonic hedgehog signals to multiple prostate stromal stem cells that replenish distinct stromal subtypes during regeneration. Proc Natl Acad Sci U S A (2013) 0.93
Promiscuous expression of H2B-GFP transgene in hematopoietic stem cells. PLoS One (2008) 0.93
PINing down the origin of prostate cancer. Sci Transl Med (2010) 0.93
Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathways. PLoS One (2010) 0.92
Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies. Endocr Rev (2008) 0.92
Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Res (2015) 0.90
Review: corneal epithelial stem cells, their niche and wound healing. Mol Vis (2013) 0.90
Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin Epigenetics (2010) 0.89
Modeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro. Stem Cells Dev (2010) 0.88
Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts. Biomed Res Int (2013) 0.87
Chimeric mice reveal clonal development of pancreatic acini, but not islets. Biochem Biophys Res Commun (2008) 0.87
Prostate progenitor cells proliferate in response to castration. Stem Cell Res (2014) 0.87
Establishing human lacrimal gland cultures with secretory function. PLoS One (2012) 0.87
Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Mol Cancer (2011) 0.87
Mouse models for cancer stem cell research. Toxicol Pathol (2009) 0.86
Prostate cancer stem cells. Cent European J Urol (2011) 0.84
Prostate cancer and parasitism of the bone hematopoietic stem cell niche. Crit Rev Eukaryot Gene Expr (2012) 0.84
SDF-1 activates papillary label-retaining cells during kidney repair from injury. Am J Physiol Renal Physiol (2012) 0.84
Vascular density is highest in the proximal region of the mouse prostate. Prostate (2007) 0.82
Hedgehog signaling in prostate epithelial-mesenchymal growth regulation. Dev Biol (2015) 0.81
Prostate cancer stem cell biology. Minerva Urol Nefrol (2012) 0.81
Dormancy in the stem cell niche. Stem Cell Res Ther (2012) 0.81
Targeting prostate cancer stem cells for cancer therapy. Discov Med (2012) 0.80
Castration-resistant Lgr5(+) cells are long-lived stem cells required for prostatic regeneration. Stem Cell Reports (2015) 0.80
Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate. Prostate (2010) 0.80
Prostate cancer stem cells: The case for model systems. J Carcinog (2012) 0.79
Recent advances in prostate development and links to prostatic diseases. Wiley Interdiscip Rev Syst Biol Med (2013) 0.79
Cytokeratin 18 is not required for morphogenesis of developing prostates but contributes to adult prostate regeneration. Biomed Res Int (2013) 0.79
Emergence of an Apical Epithelial Cell Surface In Vivo. Dev Cell (2016) 0.79
Prostate epithelial stem and progenitor cells. Am J Clin Exp Urol (2014) 0.79
Identification of tympanic border cells as slow-cycling cells in the cochlea. PLoS One (2012) 0.79
Detection and organ-specific ablation of neuroendocrine cells by synaptophysin locus-based BAC cassette in transgenic mice. PLoS One (2013) 0.78
Stem Cell Antigen-1 Identifies a Distinct Androgen-Independent Murine Prostatic Luminal Cell Lineage with Bipotent Potential. Stem Cells (2015) 0.78
Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate. Am J Physiol Renal Physiol (2015) 0.77
Stem cells in genetically-engineered mouse models of prostate cancer. Endocr Relat Cancer (2015) 0.77
The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells. Stem Cells Int (2016) 0.76
Dissecting cell-type-specific roles of androgen receptor in prostate homeostasis and regeneration through lineage tracing. Nat Commun (2017) 0.75
The many ways to make a luminal cell and a prostate cancer cell. Endocr Relat Cancer (2015) 0.75
Cancer stem cells in prostate cancer. Transl Androl Urol (2013) 0.75
Label retention and stem cell marker expression in the developing and adult prostate identifies basal and luminal epithelial stem cell subpopulations. Stem Cell Res Ther (2017) 0.75
Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells. Biomed Res Int (2013) 0.75
Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression. J Cancer (2015) 0.75
s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells. Oncotarget (2016) 0.75
TGF-β and stem cell factor regulate cell proliferation in the proximal stem cell niche. Prostate (2011) 0.75
Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate. PLoS One (2015) 0.75
Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development (2017) 0.75
Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation. Nat Commun (2016) 0.75
Comment on basal epithelial stem cells as efficient targets for prostate cancer initiation. Stem Cell Res Ther (2010) 0.75
Characterization of slow-cycling cells in the mouse cochlear lateral wall. PLoS One (2017) 0.75
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell (1990) 12.13
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development (1990) 8.37
Collagen substrata for studies on cell behavior. J Cell Biol (1972) 7.00
Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell (2000) 6.93
Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell (1989) 6.49
Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell (2001) 6.37
Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A (1987) 6.30
Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol (1986) 5.96
Liver regeneration. J Hepatol (2000) 5.22
Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol (2000) 5.04
Telomerase activity in human germline and embryonic tissues and cells. Dev Genet (1996) 5.00
Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med (2000) 4.25
Differentiation and proliferation of hematopoietic stem cells. Blood (1993) 4.02
Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol (1999) 3.59
The endocrinology and developmental biology of the prostate. Endocr Rev (1987) 3.58
Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol (1988) 3.20
Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A (2000) 3.12
Highly persistent label-retaining cells in the hair follicles of mice and their fate following induction of anagen. J Invest Dermatol (1999) 2.95
Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J Cell Sci (1998) 2.78
Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate (1987) 2.70
Epidermal stem cells: properties, markers, and location. Proc Natl Acad Sci U S A (2000) 2.66
Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med (1999) 2.52
Morphogenesis of ductal networks in the mouse prostate. Biol Reprod (1986) 2.27
Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate (1996) 2.21
Hepatic stem cells in liver regeneration. FASEB J (1996) 2.07
Functional isolation and characterization of human hematopoietic stem cells. Science (1995) 1.92
Stem cells in epithelial tissues. Science (2000) 1.80
The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate (1994) 1.79
Morphological and histological study of castration-induced degeneration and androgen-induced regeneration in the mouse prostate. Biol Reprod (1986) 1.62
Stem cell features of benign and malignant prostate epithelial cells. J Urol (1998) 1.62
Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate (1998) 1.61
Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate (1987) 1.47
Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump. Carcinogenesis (1990) 1.34
Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med (1991) 1.27
The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. Prostate (1999) 1.25
Ex vivo expansion of hematopoietic stem and progenitor cells--robbing Peter to pay Paul? Blood (1993) 1.24
Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol (1994) 1.21
Morphological and functional heterogeneity in the rat prostatic gland. Biol Reprod (1991) 1.16
Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta. J Cell Sci (1999) 1.15
Transforming growth factor-beta in benign and malignant prostate. Prostate (1999) 1.14
Prostatic ductal system in rats: regional variation in stromal organization. Prostate (1996) 1.08
Whole-mount autoradiography study of DNA synthetic activity during postnatal development and androgen-induced regeneration in the mouse prostate. Biol Reprod (1986) 1.04
Prostatic ductal system in rats: regional variation in morphological and functional activities. Biol Reprod (1990) 1.04
Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology (1991) 1.03
Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay. Stem Cells (2000) 1.01
Ductal heterogeneity of cytokeratins, gene expression, and cell death in the rat ventral prostate. Mol Endocrinol (1990) 1.00
Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate. Cancer Res (1991) 0.99
Hepatic stem cells. Gut (2000) 0.98
Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-beta 1. Prostate (1997) 0.97
Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology (1996) 0.93
Cell proliferation studies in rat prostate. I. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate (1987) 0.92
Evidence of stem cells in the adult prostatic epithelium based upon responsiveness to mesenchymal inductors. Prostate (1996) 0.91
Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor. Prostate (2000) 0.91
Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. J Cell Physiol (2000) 0.88
Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1. J Cell Physiol (2000) 0.88
Experimental induction of neoplasia in the accessory sex organs of male Lobund-Wistar rats. Cancer Res (1990) 0.88
Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptotic elimination. J Cell Biol (1997) 0.85
Seasonal variations in testicular LH, FSH, and PRL receptors; in vitro testosterone production; and serum testosterone concentration in adult male vizcacha (Lagostomus maximus maximus). Gen Comp Endocrinol (1993) 0.83
Reconstruction of prostatic acinus-like structure from ventral and dorsolateral prostatic epithelial cells of the rat in three-dimensional collagen gel matrix culture. J Urol (1997) 0.83
Telomerase activity in normal adult Brown Norway rat seminal vesicle: regional distribution and age-dependent changes. Endocrinology (1998) 0.83
Cycling activity of benign prostatic epithelial cells during long-term androgen blockade: evidence for self-renewal of luminal cells. J Pathol (1998) 0.83
Serum-free culture of enriched mouse anterior and ventral prostatic epithelial cells in collagen gel. In Vitro Cell Dev Biol (1990) 0.82
Ductal heterogeneity in rat dorsal-lateral prostate. Prostate (1996) 0.81
Circannual changes in serum testosterone concentrations of adult and yearling woodchucks (Marmota monax). Biol Reprod (1985) 0.80
Testicular and serum testosterone variations in squirrel monkeys during seasonal cyclicity. J Androl (1986) 0.78
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature (2006) 7.01
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA (2013) 3.40
Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A (2005) 2.77
Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp Eye Res (2004) 2.58
Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol (2010) 2.31
Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol (2009) 2.11
Gleason 6 prostate cancer: serious malignancy or toothless lion? Oncology (Williston Park) (2014) 2.06
Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy. J Urol (2005) 1.98
Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol Renal Physiol (2002) 1.91
Uroplakins in urothelial biology, function, and disease. Kidney Int (2009) 1.79
Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy. Urology (2010) 1.78
An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida. J Urol (2005) 1.78
Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol (2006) 1.76
Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol (2004) 1.69
High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells (2009) 1.67
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. J Urol (2003) 1.67
Ten-year outcomes of sexual function after radical prostatectomy: results of a prospective longitudinal study. Eur Urol (2013) 1.62
Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. J Clin Invest (2007) 1.59
Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol (2010) 1.58
Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy. Urology (2013) 1.56
Does a nerve-sparing technique or potency affect continence after open radical retropubic prostatectomy? BJU Int (2008) 1.53
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms. J Urol (2007) 1.50
Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res (2006) 1.44
A single nucleotide polymorphism within the novel sex-linked testis-specific retrotransposed PGAM4 gene influences human male fertility. PLoS One (2012) 1.44
Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement. J Cell Biol (2005) 1.44
Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia. Urology (2011) 1.43
Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells (2006) 1.43
Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol (2003) 1.40
Appearance of new tetraspanin genes during vertebrate evolution. Genomics (2008) 1.39
Comprehensive preoperative evaluation and repair of inguinal hernias at the time of open radical retropubic prostatectomy decreases risk of developing post-prostatectomy hernia. BJU Int (2012) 1.39
Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem (2005) 1.38
Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol (2007) 1.36
TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol (2005) 1.35
Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution. J Cell Biol (2006) 1.34
Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum. Mol Biol Cell (2002) 1.33
Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly. J Cell Biol (2002) 1.31
Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int (2004) 1.28
Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer. J Urol (2006) 1.28
Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking. Mol Biol Cell (2005) 1.27
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J (2002) 1.27
Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol (2004) 1.27
Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience. Rev Urol (2010) 1.25
Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci (2007) 1.25
ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem (2004) 1.23
Tailbud-derived mesenchyme promotes urinary tract segmentation via BMP4 signaling. Development (2007) 1.23
Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J Biol Chem (2006) 1.22
Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim Biophys Acta (2005) 1.22
A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol (2008) 1.22
Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra. Cell Tissue Res (2001) 1.21
Rab27b is associated with fusiform vesicles and may be involved in targeting uroplakins to urothelial apical membranes. Proc Natl Acad Sci U S A (2003) 1.20
Hair follicle stem cells. J Investig Dermatol Symp Proc (2003) 1.19
Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy. Urology (2003) 1.18
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. Hum Pathol (2007) 1.18
A survivin gene signature predicts aggressive tumor behavior. Cancer Res (2005) 1.17
Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res (2002) 1.16
De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure. J Am Soc Nephrol (2005) 1.15
Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle. J Mol Biol (2002) 1.14
Skin preparation for the prevention of surgical site infection: which agent is best? Rev Urol (2009) 1.14
Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. Cancer Res (2009) 1.13
Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol (2003) 1.12
Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. Rev Urol (2009) 1.12
Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest (2005) 1.11
Bmp7 expression and null phenotype in the urogenital system suggest a role in re-organization of the urethral epithelium. Gene Expr Patterns (2008) 1.09
Post-prostatectomy incontinence during sexual activity: a single center prevalence study. J Urol (2011) 1.09
Use of nitrocellulose membranes for protein characterization by matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2006) 1.09
The prostatic utricle is not a Müllerian duct remnant: immunohistochemical evidence for a distinct urogenital sinus origin. J Urol (2004) 1.08
Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. AJR Am J Roentgenol (2004) 1.08
Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer. PLoS One (2009) 1.08
Structural basis of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle. J Cell Sci (2003) 1.08
Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy. J Urol (2009) 1.07
[A case report of retrocaval ureter associated with right ureteral tumors]. Hinyokika Kiyo (2011) 1.07
The development of the bladder trigone, the center of the anti-reflux mechanism. Development (2007) 1.06
Gene deletion in urothelium by specific expression of Cre recombinase. Am J Physiol Renal Physiol (2005) 1.06
Outcomes for men younger than 50 years undergoing radical prostatectomy. Urology (2005) 1.05